Skip to search formSkip to main contentSkip to account menu

Acute Myeloid Leukemia with Mutated NPM1

Known as: AML with Mutated NPM1, Acute Myeloid Leukemia with Cytoplasmic Nucleophosmin, NPMc+ AML 
An acute myeloid leukemia with mutation of the nucleophosmin gene. It is usually associated with normal karyotype and frequently has myelomonocytic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
  • D. Arber
  • 2019
  • Corpus ID: 56675004
In 2016 a revision of the World Health Organization (WHO) classification of acute myeloid leukemia (AML) was introduced that… 
2018
2018
The presence of measurable residual disease after therapy is a significant risk factor of relapse in patients with acute myeloid… 
Highly Cited
2013
Highly Cited
2013
The World Health Organization (WHO) classifies acute myeloid leukemia (AML) via genetic, immunophenotypic, biological, and… 
Review
2010
Review
2010
The World Health Organization (WHO) classification of lympho-hematopoietic neoplasms is increasingly based on genetic criteria… 
2010
2010
The NPM1 gene encodes for nucleophosmin, a nucleolus-located shuttling protein that is involved in multiple cell functions… 
2009
2009
Abstract 4135 Acute myeloid leukemia (AML) expressing mutated NPM1 gene and cytoplasmic nucleophosmin (NPMc+ AML) [Falini B et al… 
Review
2009
Review
2009
Purpose of review Nucleophosmin (NPM1) gene mutations, which cause aberrant cytoplasmic expression of nucleophosmin (NPMc+), are… 
Highly Cited
2009
Highly Cited
2009
Acute myeloid leukemia (AML) with mutated NPM1 usually carries normal karyotype (NK), but it may harbor chromosomal aberrations…